Morgan Stanley VIF Growth II (MEGTX)

Fund Assets	n/a
Expense Ratio	0.82%
Min. Investment	$0.00
Turnover	n/a
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	n/a

Previous Close	16.57
YTD Return	-1.03%
1-Year Return	-0.29%
5-Year Return	0.83%
52-Week Low	15.24
52-Week High	22.53
Beta (5Y)	n/a
Holdings	37
Inception Date	n/a

About MEGTX

Morgan Stanley Variable Insurance Fund, Inc. Growth Portfolio Class II is a diversified U.S. equity mutual fund specifically designed as an investment option within variable annuity and variable life insurance contracts. Its primary objective is long-term capital appreciation, achieved by investing mainly in growth-oriented equity securities of large-capitalization companies. The fund focuses on established and emerging businesses that possess sustainable competitive advantages and strong free-cash-flow yields, aiming to identify firms with robust growth potential over time. Managed by Morgan Stanley Investment Management’s experienced team, the portfolio incorporates rigorous fundamental analysis and seeks exposure across various sectors, emphasizing high-quality companies with distinct market leadership. As part of Morgan Stanley’s suite of variable insurance funds, it plays a crucial role in providing investors within insurance products access to professional equity management and growth opportunities tied to major U.S. companies, supporting long-term wealth accumulation strategies for retirement and legacy planning.

• Stock Exchange: NASDAQ
• Ticker Symbol: MEGTX
• Share Class: Class II
• Index: Russell 1000 Growth TR

Performance

MEGTX had a total return of -0.29% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.68%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
MEGIX	Class I	0.57%

Top 10 Holdings

65.24% of assets

Name	Symbol	Weight
Cloudflare, Inc.	NET	14.06%
Tesla, Inc.	TSLA	9.81%
Royalty Pharma plc	RPRX	7.87%
AppLovin Corporation	APP	5.80%
QXO, Inc.	QXO	5.70%
Roblox Corporation	RBLX	4.63%
Roivant Sciences Ltd.	ROIV	4.60%
Affirm Holdings, Inc.	AFRM	4.56%
Shopify Inc.	SHOP	4.26%
Medline Inc.	MDLN	3.97%

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Aug 28, 2026

Data Sources Report a data error